| Typicality: | 0.418 |
| Saliency: | 0.395 |
| during this high-risk period | 3 | temporal |
| in heart patients | 2 | other |
| drug → prevent → clotting | 19 |
| drug → reduce → blood clotting | 15 |
| drug → prevent → blood clotting | 9 |
| drug → inhibit → blood clotting | 6 |
| drug → prevent → unwanted blood clotting | 3 |
| drug → reduce → clotting | 3 |
| drug → inhibit → clotting | 3 |
| negative | neutral | positive |
| 0.445 | 0.474 | 0.080 |
| Raw frequency | 58 |
| Normalized frequency | 0.395 |
| Modifier score | 0.500 |
| Perplexity | 84.496 |